Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coherus Oncology (CHRS) Tax Rate: 2019-2023

Historic Tax Rate for Coherus Oncology (CHRS) over the last 2 years, with Sep 2023 value amounting to 0.95%.

  • Coherus Oncology's Tax Rate was N/A to 0.95% in Q3 2023 from the same period last year, while for Dec 2020 it was 2.60%, marking a year-over-year change of. This contributed to the annual value of 0.16% for FY2023, which is N/A change from last year.
  • Latest data reveals that Coherus Oncology reported Tax Rate of 0.95% as of Q3 2023, which was down 90.62% from 10.12% recorded in Q4 2020.
  • In the past 5 years, Coherus Oncology's Tax Rate registered a high of 10.12% during Q4 2020, and its lowest value of 0.22% during Q2 2019.
  • For the 1-year period, Coherus Oncology's Tax Rate averaged around 0.95%, with its median value being 0.95% (2023).
  • The largest annual percentage gain for Coherus Oncology's Tax Rate in the last 5 years was 517bps (2020), contrasted with its biggest fall of 106bps (2020).
  • Coherus Oncology's Tax Rate (Quarterly) stood at 4.95% in 2019, then surged by 517bps to 10.12% in 2020, then reached 0.95% in 2023.
  • Its last three reported values are 0.95% in Q3 2023, 10.12% for Q4 2020, and 0.71% during Q3 2020.